WIM
DGX icon

Westside Investment Management’s Quest Diagnostics DGX Stock Holding History

Westside Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.27K Hold
39
– – ﹤0.01% 1167
2026
Q1 		$7.72K Hold
39
– – ﹤0.01% 1168
2025
Q4 		$6.78K Hold
39
– – ﹤0.01% 1187
2025
Q3 		$7.1K Hold
39
– – ﹤0.01% 1204
2025
Q2 		$6.99K Buy
+39
New +$6.77K ﹤0.01% 1074
2017
Q1 		– Sell
-125
Closed -$11.7K – 768
2016
Q4 		$11.7K Buy
+125
New +$10.8K 0.01% 366

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Westside Investment Management's DGX Position: Q2 2026 in Review

Westside Investment Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 39 shares worth $8.27K. The position accounts for ﹤0.01% of the portfolio, ranked #1167.

Westside Investment Management first reported a position in DGX in Q4 2016 and has held it in 6 quarters since. The position peaked at $11.7K in Q4 2016. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Westside Investment Management held 39 shares of Quest Diagnostics worth $8.27K as of Q2 2026.
  • Westside Investment Management left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Westside Investment Management's portfolio in Q2 2026, its #1167 holding.
  • Westside Investment Management first reported a position in Quest Diagnostics in Q4 2016 and has held it in 6 quarters since.
  • Westside Investment Management's Quest Diagnostics position peaked at $11.7K in Q4 2016.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.